Robert Listernick

1.9k total citations
46 papers, 1.2k citations indexed

About

Robert Listernick is a scholar working on Surgery, Neurology and Epidemiology. According to data from OpenAlex, Robert Listernick has authored 46 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 13 papers in Neurology and 13 papers in Epidemiology. Recurrent topics in Robert Listernick's work include Neurofibromatosis and Schwannoma Cases (13 papers), Meningioma and schwannoma management (8 papers) and Vascular Malformations Diagnosis and Treatment (6 papers). Robert Listernick is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (13 papers), Meningioma and schwannoma management (8 papers) and Vascular Malformations Diagnosis and Treatment (6 papers). Robert Listernick collaborates with scholars based in United States, Australia and Canada. Robert Listernick's co-authors include Joel Charrow, Mark J. Greenwald, David H. Gutmann, Roger J. Packer, David N. Louis, Nancy B. Esterly, Robert R. Tanz, Genie Roosevelt, Jacqueline Grupp‐Phelan and Karen Sheehan and has published in prestigious journals such as The Lancet, JAMA and Annals of Neurology.

In The Last Decade

Robert Listernick

40 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Listernick United States 11 794 641 192 189 165 46 1.2k
Ciarán J. Powers United States 18 547 0.7× 278 0.4× 146 0.8× 290 1.5× 356 2.2× 66 1.1k
Ming-Yuan Tseng United Kingdom 17 835 1.1× 264 0.4× 110 0.6× 225 1.2× 275 1.7× 30 1.3k
Abdulhakim B. Jamjoom Saudi Arabia 20 326 0.4× 172 0.3× 126 0.7× 82 0.4× 359 2.2× 101 997
William A. Shucart United States 21 1.2k 1.5× 248 0.4× 102 0.5× 220 1.2× 337 2.0× 35 1.8k
Slaven Pikija Austria 20 322 0.4× 488 0.8× 39 0.2× 321 1.7× 87 0.5× 66 878
José Carlos Esteves Veiga Brazil 14 309 0.4× 155 0.2× 50 0.3× 95 0.5× 192 1.2× 108 662
Robert A. Whaley United States 15 189 0.2× 125 0.2× 105 0.5× 128 0.7× 127 0.8× 33 644
Gianvincenzo Sparacia Italy 16 142 0.2× 121 0.2× 113 0.6× 128 0.7× 133 0.8× 67 677
Shifra Fraifeld Israel 15 253 0.3× 196 0.3× 63 0.3× 129 0.7× 245 1.5× 28 733
Hakan Selçuk Türkiye 14 293 0.4× 147 0.2× 29 0.2× 152 0.8× 124 0.8× 42 547

Countries citing papers authored by Robert Listernick

Since Specialization
Citations

This map shows the geographic impact of Robert Listernick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Listernick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Listernick more than expected).

Fields of papers citing papers by Robert Listernick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Listernick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Listernick. The network helps show where Robert Listernick may publish in the future.

Co-authorship network of co-authors of Robert Listernick

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Listernick. A scholar is included among the top collaborators of Robert Listernick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Listernick. Robert Listernick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aschbacher‐Smith, Lindsey, Allison L. Goetsch, Katherine Kim, et al.. (2024). Expanding the phenotype of neurofibromatosis type 1 microdeletion syndrome. American Journal of Medical Genetics Part C Seminars in Medical Genetics. 196(4). e32095–e32095.
2.
Listernick, Robert, et al.. (2015). Strabismus in patients with neurofibromatosis type 1–associated optic pathway glioma. Journal of American Association for Pediatric Ophthalmology and Strabismus. 19(5). 422–425. 7 indexed citations
3.
Listernick, Robert. (2014). A 6-Year-Old Male with Daily Fever Accompanied by Nausea and Abdominal Pain. Pediatric Annals. 43(6). 210–213. 1 indexed citations
4.
Listernick, Robert. (2013). A 9-Year-Old Girl with Recurrent Infections. Pediatric Annals. 42(5). 184–186. 1 indexed citations
5.
Listernick, Robert. (2013). A 13-Year-Old Boy with Elevated BUN and Creatinine. Pediatric Annals. 42(3). 96–98. 1 indexed citations
6.
Avery, Robert A., Rosalie E. Ferner, Robert Listernick, et al.. (2012). Visual acuity in children with low grade gliomas of the visual pathway: implications for patient care and clinical research. Journal of Neuro-Oncology. 110(1). 1–7. 55 indexed citations
7.
Johnson, Kimberly, Michael J. Fisher, Robert Listernick, et al.. (2012). Parent-of-origin in individuals with familial neurofibromatosis type 1 and optic pathway gliomas. Familial Cancer. 11(4). 653–656. 5 indexed citations
8.
Listernick, Robert. (2010). A 6-year-old Girl with ‘Pink Eye’ for Several Months. Pediatric Annals. 39(5). 267–270. 2 indexed citations
9.
Listernick, Robert. (2009). A 7-year-old Boy with Behavioral Problems. Pediatric Annals. 38(2). 72–75. 1 indexed citations
10.
Listernick, Robert. (2008). A 4-year-old Girl with Neurofibromatosis Type 1 and Hepatosplenomegaly. Pediatric Annals. 37(10). 658–663.
11.
Listernick, Robert. (2007). A 9-year-old Girl Who is Unable to Walk. Pediatric Annals. 36(7). 379–382. 1 indexed citations
12.
Listernick, Robert. (2007). A 9-year-old Boy with Labored Breathing. Pediatric Annals. 36(5). 254–257. 1 indexed citations
13.
Listernick, Robert. (2006). A 17-month-old Boy With Fever of Unknown Origin. Pediatric Annals. 35(3). 152–158. 1 indexed citations
14.
Listernick, Robert. (2002). A Newborn With Abdominal Distention. Pediatric Annals. 31(5). 284–287. 1 indexed citations
15.
Listernick, Robert, Crystal F. Darling, Mark J. Greenwald, Lewis C. Strauss, & Joel Charrow. (1995). Optic pathway tumors in children: The effect of neurofibromatosis type 1 on clinical manifestations and natural history. The Journal of Pediatrics. 127(5). 718–722. 140 indexed citations
16.
Charrow, Joel, Robert Listernick, & Kenneth Ward. (1993). Autosomal dominant multiple café‐au‐lait spots and neurofibromatosis‐1: Evidence of non‐linkage. American Journal of Medical Genetics. 45(5). 606–608. 35 indexed citations
17.
Listernick, Robert, et al.. (1992). Citrobacter freundii septic arthritis. Journal of Paediatrics and Child Health. 28(5). 402–403. 7 indexed citations
18.
Listernick, Robert & Joel Charrow. (1990). Neurofibromatosis type 1 in childhood. The Journal of Pediatrics. 116(6). 845–853. 88 indexed citations
19.
Listernick, Robert, Joel Charrow, Mark J. Greenwald, & Nancy B. Esterly. (1989). Optic gliomas in children with neurofibromatosis type 1. The Journal of Pediatrics. 114(5). 788–792. 221 indexed citations
20.
Fuchs, Susan & Robert Listernick. (1987). Hypernatremia and metabolic alkalosis as a consequence of the therapeutic misuse of baking soda. Pediatric Emergency Care. 3(4). 242–243. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026